Smoking enhances risk for new external genital warts in men

International Journal of Environmental Research and Public Health

Volumn 6, Issue 3, 2009, Pages 1215-1234

  Wiley, Dorothy J ^a   Off, David Elash ^a,b   Masongsong, Emmanuel V ^a   Harper, Diane M ^c   Gylys, Karen H ^a   Silverberg, Michael J ^d   Cook, Roberl L ^e   Johnson Hill, Lisetle M ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d KAISER PERMANENTE   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Genital warts; HIV; Human papillomavirus (hpv); Inai who have sex with men (msm); Longitudinal'cohort; Smoking ; Tobacco

Indexed keywords

ADULT; ARTICLE; BEHAVIOR; CONDYLOMA ACUMINATUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; SMOKING; WART VIRUS;

HUMAN PAPILLOMAVIRUS; NICOTIANA TABACUM;

EID: 67649205686     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph6031215     Document Type: Article

References (84)

1. Wiley, D.J.; Douglas, J.; Beuliier, K.; Cox, T.; Fife, K.; Moscicki, A.B.; Fukumoto, L External genital warts diagnosis, treaun ait, and prevention. Clin. Infect Da. 2002, 35, S2I0-S224.
2. Deacon, J.M.; Evans, CD.; Yule,R.; Desai, M.; Binns, W.; Taylor, C; Peto, J. Sexual behaviour and smoking as determinants of cervical HPV infection and of C1N3 among those infected a case-control stud)' nested within the Manchester cohort. Br. J. Cancer. 2000, 83, 1565-1572.
3. Castle, P.E.; Wacholder, S.; Lorincz, A.T.; Scott, D.R.; Sherman, M.E.; Qass, A.G.; Rush, B.B.; Schussler, J.E.; Schiflinan, M. A prospective study of high-grade cervical neoplasia risk among human papilloinavirus-infected women. J. Natl. Cancer Inst. 2002, 94, 1406-1414.
4. Feldman, J.G.; Giirgwin,K.; Dehovitz, J.A.; Minkoff, H. The association of smoking and risk of condyloma acuminatum in women. Obs. Gynecol. 1997, 89, 346-350.
5. Moscicki, A.B.; Hills, N.; Shiboski, S.; Powell, K.; Jay, N.; Hanson, E.; Miller, S.; Clayton, L; Farhat, S.; Broering, J.; et al. Risks for incident human papillomavirus infection and low-grade squamous mtraqwtheh al I esion development in young feinal es. JAMA 2001, 285, 2995-3002.
6. Hocke; C; Leroy, V.; Mortal, P.; Rivd, J.; Duluc, M.C.; Boulogne, N.; Tan don net, B.; Dupon, M.; Brim. J.L.; Dabis, F. Cervical dysplasia and human inmmunodeficiency virus infection in women: prevalence and associated factors. Groupe d'Epidaniologie Cliniqiic du S1DA en Aquitaine(GESCA). Ear. J. Obstet. Gynecol. Reprod. Biol. 1998, 81, 69-76.
7. Ho, G.Y.; Bierman, R.; Beards! ey, L; Chang, C.J.; Burk, R.D. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med 1999, 338, 423-428.
8. Hildesheim, A.; Herrero, R.; Castle, P.E.; Wacholder, S.; Bratti, M.C.; Sherman, M.E.; Lorincz, A.T.; Burk, R.D.; Morales, J.; Rodriguez, A.C; et al. HPV co-factors related to the development of cervical cancer: results from a population-based stud)' in Costa Rica Br. J. Cancer. 2001, 84, 1219-1226.
9. Lacey, J.V., Jr.; Frisch,M.; Brinton, L.A.; Abbas, F.M.; Barnes, W.A.; Gravitt, P.E.; Greenberg, M.D.; Greene, S.M.;Hadjhnichael, O.C.;McGowan, L.; et al. Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control 2001, 12, 153-161.
10. Giuliano, A.R.; Sedjo.R.L.; Roe, D.J.; Hani, R.; Baldwi, S.; Papenfuss, M.R.; Abrahamsen, M.; Inserra, P. Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control 2002, 13, 839-846.
11. Bradbeer, C. Is infection with HIV a risk factor for cervical intraepithelial neoplasia? J Lancet. 1987, 2, 1277-1278.
12. Cervical dysplasia and HIV infection [letter]. J Lancet. 1988, 1, 237-239.
13. Maiman,M.;Fruchter, R.G.; Serur, E.;Boyce, J.G Prevalence ofhuman immunodeficiency virus in a colposcopy clinic. JAMA 1988, 260, 2214-2215.
14. Byrne, M.A.; Taylor-Robinson, D.;Munday, P.E.; Harris, J.R. The common occurrence of human papillomavirus infection and intraepithelial neoplasia in women infected by HIV, J Acquir. Immune Defie. Syndr. 1989, 3, 379-382.
15. Schrager, L.K.; Fried and, G.H.; Maude, D.; Schreiber, K.; Adachi, A.;Pizaiti,D.J.; Koss, L.G.; Klein, R.S. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir. Immune Defic. Syndr. 1989, 2, 570-575.
16. Feingold, A.R.; Vermund, S.H.; Burk, R.D.; Kdley, K.F.; Schrager, L.K.; Schreiber, K.; Munk, G.; Fried and, G.H.; Klein, R.S. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus J. Acquir. Immune Defic. Syndr. 1990, 3, 896-903.
17. Maiman, M.; Fruchter, R.G.; Serur, E.; Remy, J.C.; Feuer, G; Boyce, J. Human immunodeficiency virus infection and cervical neoplasia Gynecol. Oncol. 1990, 38 377-382.
18. Palefsky, J. Human papillomavirus infection among HIV-infected individuals. Implications for development of malignant tumors. Hemaiol. Oncol. Clin. North Am 1991, 5, 357-370.
19. Wiley, D.J.; Harper, D.M.; Elashoff, D.; Silverberg, M.J.; Kaestle, C.; Cook, R.L; Heilemann, M; Johnson, L How condom use, number of receptive anal intercourse partners and history of external genital warts predict risk for external anal warts. Int. J. STD AIDS 2005, 16, 203-211.
20. Wiley, D.J.; Visscher, B.R.; Grosser, S.; Hoover, D.R.; Day, R.; Gange, S.; Chmiel, J.S.; Mitsuyasu, R.; Detds, R. Evidence that anoreceptive intercourse with ejaculate exposure is associated with rapid CD4 cdl loss. J Acquir. Immune Defic. Syndr. 2000, 14, 707-715.
21. Phair, J.; Jacobson, L.; Ddds, R.; Rinaldo, C; Saah, A.; Schrager, L; Munoz, A. Acquired immune defidency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J. Acquir. Immune Defic. Syndr. 1992, 5, 490-496.
22. Park, L.P.; Margolick, J.B.; Giorgi, J.V.; Ferbas, J.; Bauer, K.; Kadow, R.; Munoz, A. Influaice of HIV -1 infection and dgardte smoking on leukocyte profiles in homosexual men. The Multicaiter AIDS Cohort Study. J. Acquir. Immune Defic. Syndr. 1992, 5, 1124-1130.
23. Strickler, H.D.; Burk, R.D.; Fazzari, M.; Anastos, K.; Minkoff, H.; Massad, L.S.; Hall, C; Bacon, M.; Levine, A.M.; Watts, D.H.; et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl. Cancer Inst. Monographs. 2005, 97, 577-586.
24. Carter, P.S.; de Ruiter, A.; Whatrup, C; Katz, D.R.; Ewings, P.; Mindd, A.; Nortliover, J.M. Human immunodeficiency virus infection and genital warts as risk fadors for anal mtraepithdial neoplasi a in horn osexual men. Br. J. Surg. 1995, 82, 473-474.
25. Scott, H.; Khoury, J.; Moore, B.A.; Weissman, S. Routine anal cytology screening for anal squamous mtraepithdial lesions in an urban HIV clinic. Sex. Transm. Dis. 2008, 35, 197-202.
26. Insigna,R.P.;Dasbach, E.J.; Myers, E.R. The health and economic burden of genital warts in a set of private health plans in the United States. Clin. Infect. Dis. 2003, 56, 1397-1403.
27. Franco, E.L; Rohan, T.E.; Villa, L.L Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J. Natl. Cancer Inst. Monographs. 1999, 91, 506-511.
28. Moscicki, A.B.; Shiboski, S.; Broering, J.; Powell, K.; Clayton, L; Jay, N.; Darragli, T.M.; Brescia, R.; Kanowitz, S.; Miller, S.B.; el al. Tlie natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J. Pediatr. 1998, 132, 731-284.
29. Wiley,D.J.; Huh, J.; Rao, J.Y.; Chang, C; Goetz,M.; Poulter,M.; Masongsong, E.; Chang, C.I.; Bernard, H.U. Metliylation of human papillomavirus genomes in cells of anal epithdia of HIV- infectedmen. J Acquir. Immune Defic. Syndr. 2005, 59, 143-151.
30. Kalantari, M.; Calleja-Madas, I.E.; Tewari, D.; Hagmar, B.; Lie, K.; Barrera-Saldana, H.A.; Wiley, D.J.; Bernard, H.U. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J. Virol. 2004, 78, 12762-12772.
31. Badal, S.; Badal, V.; Calleja-Madas, I.E.; Kalantari, M.; Qiuang, L.S.; Li, B.F.; Bernard, H.U. The human papillomavirus-18 genome is efficiently targded by cdlular DNA metliylation. Virology 2004, 324, 483-492.
32. Badal,V.; Chuang, L.S.; Tan, E.H.;Badal, S.; Villa, L.L; Wheeler, CM.; Li,B.F.; Beniard,H.U. CpG metliylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation corrdates with carcinogenic progression. J. Virol. 2003, 77, 6227-6234.
33. Kim, K.; Garner-Hamrick, P.A.; Fisher, C; Lee, D.; Lambert, P.F. Metliylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J. Virol. 2003, 77, 12450-12459.
34. Franco, E.L The sexually transmitted disease modd for cervical cancer: incoherent epidemiologic findings and tlie role of misclassification of human papillomavirus infection. Epidemiology 1991, 2, 98-106.
35. Wen, L.M.; Estcourt, C.S.; Simpson, J.M.; Mindel, A. Risk factors for the acquisition of genital warts: are condoms protective? Sex. Transm. Infect 1999, 75, 312-316.
36. Syrjanai, K.; Shabalova, 1.; Petrovichev, N.; Kozachenko, V.; Zakharova, T; Pajanid, J.; Podisiov, J.; Chemeris, G.; Sozaeva, L; Lipova, E.; et al. Smoking is an indepaident risk fador for oncogenic human papillomavirus (HFV) infections but not for high-grade C1N. Eur. J. Epidemiol. 2007, 22, 723-735.
37. Ho, G.Y.; Kadish, A.S.; Burk, R.D.; Basu, J.; Palan, P.R.; Mikhail, M.; Romney, S.L HPV 16 and cigarette smoking as risk fadors for high-grade cervical intra-epithdial neoplasia Int. J. Cancer 1998, 78, 281-285.
38. Dating, J.R.; Sherman, K.J. Relationship between human papillomavirus infection and tumours of anogenital sites other that the cervix. IARC Sci Publ. 1992, 119, 223-241.
39. Franceschi, S. The 1ARC commitment to cancer prevention: the example of papillomavirus and cervi cal cancer. Recent Results Cancer Res. 2005, 166, 277-297.
40. Munoz, N.; Bosch, F.X.; de Sanjose, S.; Vergara, A.; del Moral, A.; Munoz, M.T.; Tafur, L.; Gili, M.; Izarzugaza, 1.; Viladiu, P.; et al. Risk fadors for cervical mtraepithdial neoplasia grade lll'cardnoma in situ in Spain and Colombia. Cancer Epidemiol. Biomarkers Prev. 1993, 2, 423- 431.
41. Palefsky, J.M.; Holly, E.A.; Ralslon, M.L; Arlliur, S.P.; Hogeboom, C.J.; Darragh, T.M. Anal
42. cyiological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease. Genitourin. Med 1997, 73, 174-180.
43. Critchlow, C.W.; Hawes, S.E.; Kuypers, J.M.; Goldbauin, G.M.; Holmes, K.K.; Suravvicz, CM.; Kiviat, N.B. Effect of HIV infection on the natural hi dory of anal human papillomavirus infection. J Acquir. Immune Defic Syndr. 1998, 12, 1177-1184.
44. Massad, L.S.; Silverberg, M.J.; Springer, G.; Minkoff, H.; Hessol, N; Palefsky, J.M.; Strickler, H.D.; Levin e, A.M.; Sacks, H.S.; Moxley, M.; et al. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am. J. Obstet. Gynecol. 2004, 190, 1241-1248.
45. Ali, S.; Astley, S.B.; Sheldon, T.A.; Peel, K.R.; Wells, M. Detection and measurement of DNA adductsin the cervix of smokers and non-smokers. Int. J. Gynecol. Cancer 1994, 4, 188-193.
46. Prokopczyk, B.; Trushm, N.; Leszczynska, J.; Waggoner, S.E.; El-Bayoumy, K. Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-l-(3-pyridyl)-1- butanone, via alpha-hydroxviation and carbonyl reduction pathways Carcinogenesis 2001, 22, 107-114.
47. Smith, K.R.; Uyeininami, D.L; Kodavanti, U.P.; Crapo, J.D.; Chang, L.Y.; Pinkerton, K.E. Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidant. Free Radic. Biol. Med 2002, 33, 1106-1114.
48. Wang, L.E.; Cheng, L; Spitz, M.R.; Wei, Q. Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. Lung Cancer 2003, 42, 1-8.
49. Hoser, G; Doinagala-Kulavvik, J.; Droszcz, P.; Droszcz, W.; Kawiak, J. Lymphocyte subsets differences in smokers and nonsmokers with primary lung cancer: a flow cytometry analysis of bronchoalveolar lavage fluid cells. Med Sci. Marat 2003, 9, BR310-BR315.
50. Wiley, D.J.; Wiesmeier, E.; Masongsong, E.; Gylys, K.H.; Koutsky, LA.; Ferris, D.G.; Barr, E.; Yu, R.J. Smokers at higher risk for undetected antibody for oncogenic human papillomavirus type 16 infection. Cancer Epidemiol. Biom. Prev. 2000, 15, 915-920.
51. Prokopczyk, B.; Cox, J.E.; Hoffmann, D.; Waggoner, S.E. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J. Natl. Cancer Inst. 1997, 89,868- 873.
52. Melikian, A.A.; Sun, P.; Prokopczyk, B.; El-Bayoumy, K.; Hoffinann, D.; Wang, X.; Waggoner, S. Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adductsin cervical tissues in humans by gaschroinatography-mass spectrometry. Cancer Lett. 1999, 146, 127-134.
53. Duval, X.; Baron, G; Gardik, D.; Villes, V.; Dupre, T.; Leport, C; Lai, F.; Peretti-Watd, P.; Ravaud, P.; Spire, B. Living with HIV, antiretroviral treatinait experience and tobacco smoking: results from a inultisite cross-sectional study. Antivir Ther. 2008, 13, 389-397.
54. Hart, T.A.; James, C.A.; Purcdl, D.W.; Farber, E. Social anxiety and HIV transmission risk among HIY-seropositive male patiaits AIDS Patient Care STDS 2008, 22, 879-886.
55. Stall,R.D.; Greenwood, G.L; Acree, M.; Paul, J.; Coates, T.J. Cigarette smoking among gay and bisexual men. Am. J. Public Health 1999, 89, 1875-1878.
56. Lombardi, E.; Silvestre, A.J.; Janosky, J.E.; Fisher, G.; Rinaldo, C. Impact of early sexual debut on gay men's tobacco use Nicotine Toh. Res. 2008, 10,1591-1595.
57. Skinner, W.F. The prevalence and demographic predictors of illicit and licit drug use among lesbians and gay men. Am. J. Public Health 1994, 84, 1307-1310.
58. Lampinen, T.M.; Bonner, S.J.; Rusch.M.; Hogg, R.S. High prevalence of smoking among urban- dwelling Canadian men who have sex with men. J. Urban Health 2006, 83, 1143-1150.
59. Ramsey, F.; Ussery-Hall, A.; Garcia, D.; McDonald, G; Easton, A.; Kambon, M.; Balluz, L; Garvin, W.; Vigeant, J. Prevalence of selected risk behaviors and chronic diseases-Behavioral Risk Factor Surveillance System (BRFSSX 39 steps communities. United States, 2005. MMWR Surveill. Summ. 2008, 57, 1-20.
60. Palefsky, J.M.; Holly, E.A.; Hogeboom, C.J.; Ralston, M.L.; DaCosta, M.M.; Botts, R.; Berry, J.M.; Jay, N.;Darragh, T.M. Virologic, immunologic, and clinical parametersin the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J. Acquir. Immune Defic. Syndr. Hum Retroviral. 1998, 17, 314-319.
61. Breese, P.L.; Judsoii,F.N.;Penley, K.A.; Douglas, J.M., Jr. Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human immunodeficiency virus Sex. Transm. Dis. 1995, 22, 7-14.
62. Beutner, K.; Wiley, D. Recurrent External Genital Warts A Literature Review. Papillomavirus Rep. 1997, 8, 69-74.
63. Hong, K.; Greer, C.E.; Ketter, N.; van Nest, G; Paliard, X. Isolation and characterization of human papillomavirus type 6-specific T cells infiltrating genital warts. J. Virol. 1997, 71, 6427-6432.
64. Arany, 1.; Tyring, S.K. Status of local cellular immunity in mterferon-responsive and - nonresponsve human papillomavirus-associated lesions Sex. Transm. Dis. 1996, 23, 475-480.
65. Cayota, A.; Vuillier, F.; Scott-Algara, D.; Dighiero, G. Preferential replication of HIV-I in memory CD4+ subpopulation (letter]. J Lancet 1990, 336, 941.
66. Cayota, A.; Vuillier, F.; Scott-Algara, D.; Feuillie, V.; Dighiero, G. Impaired proliferative capacity and abnormal cytokine profile of naive and memory CD4 T cells from HIV-seropositive patients. Clin. Exp. Immunol. 1992, 88, 478-483.
67. Cayota, A.; Vuillier, F.; Scott-Algara, D.; Feuillie, V.; Dighiero, G. Differential requiremaits for HIV-I replication in naive and memory CD4 T cells from asymptomatic HIV-I seropositive carriers and AIDS patiaits Clin. Exp. Immunol. 1993, 91, 241-248.
68. Zack, J.A.; Cann, A.J.; Lugo, J.P.; Chen, I.S. HIV-I production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. Science 1988, 240, 1026-1029.
69. Zack, J.A.; Arrigo, S.J.; Chen, I.S. Control of expression and cell tropism of human immunodeficiency virus type 1. Adv. Virus Res. 1990, 38, 125-146.
70. Zack, J.A.; Arrigo, S.J.; Weitsman, S.R.; Go, A.S.; Haislip, A.; Chen, I.S. HIV-1 entry into quiescent primary lymphocytes molecular analysis reveals a labile, latent viral structure. Cell 1990, 61, 213-222.
71. Schnittman, S.M.; Lane, H.C.; Greenhouse, J.; Justanent, J.S.; Baseler, M.; Fauci, A.S. Preferaitial infection of CD4+ memory T cells by human immunodeficiency virus type I: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc. Natl. Acad. Sci. USA. 1990, 87, 6058-6062.
72. Arany, I.; Muldrow, M.; Tyring, S.K. Corrdation between inRNA levds of IL-6 and TNF alpha and progression rale in anal squamous epithelial lesions from HIV-positive men. Anticancer Res. 2001,.21, 425-428.
73. Dold, A.; Curreli, S.; Marongiu, P.; Pierangdi, A.; Gomes, E; Bucd, M.; Serra, C.; Degener, A.M. Human immunodefidency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the LI capsid protdn. J Gen. Virol. 1999, 80, 2937-2944.
74. Wd, LH.; Kuo, M.L.; Chen, C.A.; Cheng, W.F.; Cheng, S.P.; Hsidi, F.J.; Hsieh, C.Y. Interl cukin-6 in cervical cancer: the rdationship with vascul ar endothdi al growth factor. Gynecol. Oncol. 2001, 82, 49-56.
75. Arany, I.; Grattendick,K.J.; Whitehead, W.E; Ember, I.A.; Tyring, S.K. A fimctional interferon regulator)1 factor-l (IRF-I )-biiidmg site in the upstream regulator)1 region (URR) of human papillomavirus type 16. Virology 2003, 310, 280-286.
76. Arany, I.; Grattendick, K.G.; Tyring, S.K. lnterleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV 16) through the 5'-segment of tlie upstream regulator)'region (URR). Ant Res. 2002, 55, 331-339.
77. Cubie, H.A.; Seagar, A.L; Beattie, G.J.; Monaglian, S.; Williams, A.R. A longitudinal stud)' of HPV detection and cervical pathology in HIV infected women. Sex. Transm. Dis. 2000, 76, 257-261.
78. Eckert, L.O.; Watts,D.H.;Koutsky, L.A.; Hawes, S.E; Stevens, C.E.;Kuypers, J.;Kiviat, N.B. A matched prospective stud)' of human immunodeficiency virus serostatus, human papillomavirus DNA, and cervical lesions detected by cytology and colposcopy. Infect. Dis. Oh. Gyn. 1999, 7, 158-164.
79. Wiley.D.J. Genital warts. Clin. Evid. 2002, 1426-1436.
80. Wiley, D.J.; Grosser, S.; Q, K.; Visscher, B.R.; Beutner, K.; Strathdee, S.A.; Calhoun, B.; Paldla, F.; Detds, R. Validity of self-reporting of episodes of external genital warts. Clin. Infect. Dis. 2002, 35, 39-45.
81. Dosemed, M.; Wacholder, S.; Lubin, J.H. Does nondifferential inisclassification of exposure always bias a true effect toward tlie null value? Am. J. Epidemiol. 1990, 132, 746-748.
82. Kadow, R.A.; Ostrow, D.G.; Ddels, R.; Phair, J.P.; Polk, B.F.; Rind do, C.R., Jr. The Multicenter AIDS Cohort Study: rationale, organization, and sdeded characteristies oftheparticipants Am. J. Epidemiol. 1987, 126, 310-318.
83. Chmiel, J.S.; Detds, R.; Kadow, R.A.; van Radai, M.; Kingsley, L.A.; Brookmeyer, R. Factors associated with prevalent human immunodeficiency virus (HIV) infection in tlie Multicenter AIDS Cohort Stud)'. Am. J. Epidemiol. 1987, 126, 568-577.
84. Rotliinan, K.J.; Greenland, S. Precision and Validity in Epidemiologic Studies In Modern Epidemiology, 2"1 Ed.; Rotliinan, .K.J., Greenland, S., Eds.; Lippencott Raven: Philadelphia, Pennsylvania, USA, 1998; pp. 115-134.